Akzo Nobel N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKZOY research report →
Price Chart
About the company
Akzo Nobel N. V. operates globally as a prominent manufacturer and distributor of paints and protective coatings.
- CEO
- Gregoire Poux-Guillaume
- IPO
- 1989
- Employees
- 31,500
- HQ
- Amsterdam, NH, NL
Get TickerSpark's AI analysis on AKZOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $33.54B
- P/E
- 16.19
- Fwd P/E
- 16.65
- PEG
- 0.02
- P/S
- 1.07
- P/B
- 2.18
- EV/EBITDA
- 6.15
- Div Yield
- 3.21%
- Gross Margin
- 40.63%
- Op Margin
- 12.05%
- Net Margin
- 6.60%
- ROE
- 13.55%
- ROIC
- 6.33%
Latest fiscal year · YoY change
- Revenue
- $9.76B-8.9%
- Gross Profit
- $3.89B-10.3%
- Op Income
- $743.45M
- Net Income
- $609.94M+12.5%
- EPS
- $1.19+12.6%
- OCF Growth
- +31.6%
- FCF Growth
- +60.8%
- 52W High
- $25.99
- 52W Low
- $18.04
- 50D MA
- $22.21
- 200D MA
- $21.89
- Beta
- 1.14
- RSI (14)
- 40
- Avg Volume
- 167.47K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
AkzoNobel posted 2% organic sales growth in Q3 2026, expanded adjusted EBITDA margin for a sixth straight quarter, and reiterated full-year EBITDA guidance while advancing the Axalta merger and portfolio reshaping.· October 21, 2026
- Organic sales rose 2% in Q3, led by 5% pricing that more than offset 2% lower volumes; total revenue was flat after a 5% scope drag and 3% FX tailwind.
- Adjusted EBITDA was EUR 388 million, up EUR 15 million year over year at comparable scope and constant currencies, with margin up 20 bps to 15.3%.
- Free cash flow was EUR 119 million in Q3 and EUR 83 million year-to-date, while leverage improved to 2.1x and trade working capital fell to 15.7% of revenue.
- Management kept 2026 adjusted EBITDA guidance at around EUR 1.47 billion and expects Q4 volumes to be flat with pricing slightly positive versus raw material inflation.
- The company signed the sale of its Southeast Asia decorative paints businesses for EUR 1.2 billion enterprise value and said all proceeds will be used for deleveraging; the Axalta deal remains on track for early 2027 closing.
Q3 2026 group organic sales increased 2%. Pricing contributed 5%, volumes were down 2%, mix was down 1%, scope reduced revenue by 5%, and FX added 3%, leaving total revenue flat. Adjusted EBITDA was EUR 388 million, up EUR 15 million or 4% at comparable scope and constant currencies, and adjusted EBITDA margin improved 20 bps to 15.3%. Paints margin rose 200 bps to 19.4%. Trade working capital improved 130 bps year over year to 15.7% of revenue. Free cash flow was EUR 119 million in Q3 and EUR 83 million year-to-date. Leverage was 2.1x at quarter end. Management reiterated 2026 adjusted EBITDA guidance of around EUR 1.47 billion. For Q4, volumes are expected to be flat, pricing is expected to be slightly positive versus raw material inflation, and OpEx savings are expected as planned. The Southeast Asia decorative businesses were sold to Nippon Paint for an enterprise value of EUR 1.2 billion, with about EUR 900 million of net cash proceeds after minorities and taxes, around EUR 200 million expected in December from Indonesia, and around EUR 700 million expected in mid-2027. Management said the combined Deco portfolio review, including India and Pakistan, realized more than EUR 2.6 billion of enterprise value at a blended 23x EBITDA multiple.
Gregoire Poux-Guillaume framed the quarter as operationally solid despite weak markets, highlighting disciplined pricing, ongoing cost action, and six straight quarters of margin expansion. He emphasized that the company is sharpening its portfolio ahead of the Axalta combination, calling the Southeast Asia disposal evidence that AkzoNobel’s assets are valuable and that the merger path is clear. His tone was confident and forward-looking, especially around regulatory progress and “day 1” readiness for the combined company.
Maarten de Vries focused on the bridge from sales to earnings and cash. He said organic sales were up 2%, adjusted EBITDA was EUR 388 million, margin was 15.3%, trade working capital improved to 15.7% of revenue, ROIC rose to 13.7%, and free cash flow was EUR 119 million in Q3. He also noted transaction costs of EUR 69 million year-to-date, merger-related cash out of roughly EUR 100 million for 2026, leverage of 2.1x, and that the company remains within its target range of around 2x by year-end.
Analysts focused on the weaker volume trend, the Southeast Asia disposal, antitrust remedies, leverage, and capital allocation. Management said Q3 volume softness was mainly timing-related from pricing implementation, with weaker July and August and a stronger September, and denied that pricing is driving the volume decline. On the remedies, they said the divestitures of AkzoNobel’s European Refinish business and Axalta’s U.S. wood coatings business should not change the $600 million cost synergy target, and that Southeast Asia proceeds will help delever faster and could support a return to normal capital allocation, including buybacks. Management also said China remains weak, with no recovery expected in 2027, and that Refinish North America is still at trough.
The call showed continued margin progression, with pricing discipline and cost savings more than offsetting volume softness. Management also highlighted strong asset monetization, a clearer portfolio focus, and steady progress toward merger closing, with two-thirds of regulatory approvals already secured and all merger workstreams advancing.
Volumes remain under pressure in several end markets, including construction-linked areas, automotive, and China’s weak property market. The company also faces ongoing regulatory and remedy execution risk, plus elevated raw material inflation in the near term and merger-related cash outflows that are expected to rise versus the first half.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.0%
- Shares Outstanding
- 1.54B
- Float Shares
- 1.46B
Congressional trading
Senate and House stock disclosures for AKZOY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 15 ETFs
Biggest fund positions in AKZOY by dollar value.
Our AKZOY coverage
Recent articles, reports, and earnings notes.
No research on AKZOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AKZOY report →AkzoNobel-Axalta $25 Billion Merger Could Harm Competition, U.K. Regulator Warns
wsj.com · Nov 11
AkzoNobel, Axalta get week to address UK regulator concerns over $25 billion merger
reuters.com · Nov 11
AkzoNobel, Axalta's $25 Billion Merger Could Harm Competition, U.K. Regulator Warns
wsj.com · Nov 11
AkzoNobel , Axalta gain conditional EU antitrust approval for $25 billion merger
reuters.com · Nov 6
Ariel Global Fund Q3 2026 Performers And Detractors
seekingalpha.com · Nov 6
Ariel International Fund Q3 2026 Highlights: Trades And Trends
seekingalpha.com · Oct 30
Akzo Nobel N.V. (AKZOY) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 21
Akzo Nobel in Talks to Shed European Refinishing Unit for Axalta Merger Nod
wsj.com · Oct 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.